188 related articles for article (PubMed ID: 36936697)
1. Aberrant lipid accumulation in the mouse visceral yolk sac resulting from maternal diabetes and obesity.
Zhang M; Salbaum JM; Jones S; Burk D; Kappen C
Front Cell Dev Biol; 2023; 11():1073807. PubMed ID: 36936697
[TBL] [Abstract][Full Text] [Related]
2. Differential responses to maternal diabetes in embryo and visceral yolk sac.
Salbaum JM; Stone KP; Kruger C; Kappen C
Front Cell Dev Biol; 2023; 11():1273641. PubMed ID: 37928898
[No Abstract] [Full Text] [Related]
3. New development of the yolk sac theory in diabetic embryopathy: molecular mechanism and link to structural birth defects.
Dong D; Reece EA; Lin X; Wu Y; AriasVillela N; Yang P
Am J Obstet Gynecol; 2016 Feb; 214(2):192-202. PubMed ID: 26432466
[TBL] [Abstract][Full Text] [Related]
4. Nutrient Transporter Gene Expression in the Early Conceptus-Implications From Two Mouse Models of Diabetic Pregnancy.
Kappen C; Kruger C; Jones S; Salbaum JM
Front Cell Dev Biol; 2022; 10():777844. PubMed ID: 35478964
[TBL] [Abstract][Full Text] [Related]
5. Nitroxide radicals protect cultured rat embryos and yolk sacs from diabetic-induced damage.
Ryu S; Kohen R; Samuni A; Ornoy A
Birth Defects Res A Clin Mol Teratol; 2007 Aug; 79(8):604-11. PubMed ID: 17626261
[TBL] [Abstract][Full Text] [Related]
6. Activation of oxidative stress signaling that is implicated in apoptosis with a mouse model of diabetic embryopathy.
Yang P; Zhao Z; Reece EA
Am J Obstet Gynecol; 2008 Jan; 198(1):130.e1-7. PubMed ID: 18166327
[TBL] [Abstract][Full Text] [Related]
7. The effects of high-sucrose diets and of maternal diabetes on the ultrastructure of the visceral yolk sac endoderm in rat embryos developing in vivo and in vitro.
Zusman I; Yaffe P; Ornoy A
Acta Anat (Basel); 1987; 128(1):11-8. PubMed ID: 2950713
[TBL] [Abstract][Full Text] [Related]
8. Dietary myo-inositol therapy in hyperglycemia-induced embryopathy.
Khandelwal M; Reece EA; Wu YK; Borenstein M
Teratology; 1998 Feb; 57(2):79-84. PubMed ID: 9562680
[TBL] [Abstract][Full Text] [Related]
9. Blockade of c-Jun N-terminal kinase activation abrogates hyperglycemia-induced yolk sac vasculopathy in vitro.
Yang P; Zhao Z; Reece EA
Am J Obstet Gynecol; 2008 Mar; 198(3):321.e1-7. PubMed ID: 18177823
[TBL] [Abstract][Full Text] [Related]
10. Evidence that maternal conjugated linoleic acid negatively affects lipid uptake in late-stage chick embryos resulting in increased embryonic mortality.
Leone VA; Worzalla SP; Cook ME
Poult Sci; 2010 Apr; 89(4):621-32. PubMed ID: 20308393
[TBL] [Abstract][Full Text] [Related]
11. The green tea polyphenol EGCG alleviates maternal diabetes-induced neural tube defects by inhibiting DNA hypermethylation.
Zhong J; Xu C; Reece EA; Yang P
Am J Obstet Gynecol; 2016 Sep; 215(3):368.e1-368.e10. PubMed ID: 26979632
[TBL] [Abstract][Full Text] [Related]
12. A novel function for apolipoprotein B: lipoprotein synthesis in the yolk sac is critical for maternal-fetal lipid transport in mice.
Farese RV; Cases S; Ruland SL; Kayden HJ; Wong JS; Young SG; Hamilton RL
J Lipid Res; 1996 Feb; 37(2):347-60. PubMed ID: 9026532
[TBL] [Abstract][Full Text] [Related]
13. The role of the visceral yolk sac in hyperglycemia-induced embryopathies in mouse embryos in vitro.
Hunter ES; Sadler TW
Teratology; 1992 Feb; 45(2):195-203. PubMed ID: 1615429
[TBL] [Abstract][Full Text] [Related]
14. Embryonic cell migratory capacity is impaired upon exposure to glucose in vivo and in vitro.
Herion NJ; Kruger C; Staszkiewicz J; Kappen C; Salbaum JM
Birth Defects Res; 2019 Aug; 111(14):999-1012. PubMed ID: 30451383
[TBL] [Abstract][Full Text] [Related]
15. The Significance of Yolk Sac Number in Monoamniotic Twins.
Fenton C; Reidy K; Demyanenko M; Palma-Dias R; Cole S; Umstad MP
Fetal Diagn Ther; 2019; 46(3):193-199. PubMed ID: 30763938
[TBL] [Abstract][Full Text] [Related]
16. Apoptosis in embryos of diabetic rats.
Forsberg H; Eriksson UJ; Welsh N
Pharmacol Toxicol; 1998 Sep; 83(3):104-11. PubMed ID: 9783328
[TBL] [Abstract][Full Text] [Related]
17. Fatty acid content of yolk sac and embryo in hyperglycemia-induced embryopathy and effect of arachidonic acid supplementation.
Pinter E; Reece EA; Ogburn PL; Turner S; Hobbins JC; Mahoney MJ; Naftolin F
Am J Obstet Gynecol; 1988 Dec; 159(6):1484-90. PubMed ID: 3144918
[TBL] [Abstract][Full Text] [Related]
18. Studies on the mechanism of trypan blue teratogenicity in the rat developing in vivo and in vitro.
Rogers JM; Daston GP; Ebron MT; Carver B; Stefanadis JG; Grabowski CT
Teratology; 1985 Jun; 31(3):389-99. PubMed ID: 4012648
[TBL] [Abstract][Full Text] [Related]
19. Cellular-tissue localization and regulation of the GLUT-1 protein in both the embryo and the visceral yolk sac from normal and experimental diabetic rats during the early postimplantation period.
Trocino RA; Akazawa S; Takino H; Takao Y; Matsumoto K; Maeda Y; Okuno S; Nagataki S
Endocrinology; 1994 Feb; 134(2):869-78. PubMed ID: 8299581
[TBL] [Abstract][Full Text] [Related]
20. Role of reactive oxygen species (ROS) in the diabetes-induced anomalies in rat embryos in vitro: reduction in antioxidant enzymes and low-molecular-weight antioxidants (LMWA) may be the causative factor for increased anomalies.
Ornoy A; Zaken V; Kohen R
Teratology; 1999 Dec; 60(6):376-86. PubMed ID: 10590399
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
